Research reveals that altering gut microbiota may slow disease progression in retinitis pigmentosa, suggesting new treatment avenues.
Patients with RP exhibited distinct gut microbiota characteristics compared to that of healthy individuals. Treatment with antibiotics attenuated disease progression in the RP model mouse. Modifying the gut microbiota may be a potential therapeutic strategy for modifying disease progression in RP in future investigations.
No takes yet. Share an insight, caveat, or question.
Bagel et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: